Release Date: 10/01/13 12:49 Summary: Release of Escrowed Shares Price Sensitive: No Download Document 273.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%